Solid Biosciences Inc. SEC filings SLDB
Solid Biosciences Inc. has 737 filings in SEC EDGAR's recent list, going back to Aug 4, 2017. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 31, 2026 | — |
| EFFECT | Filing | Mar 31, 2026 | — |
| CORRESP | Letter to the SEC | Mar 27, 2026 | — |
| CORRESP | Letter to the SEC | Mar 27, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2026 | — |
| EFFECT | Filing | May 27, 2025 | — |
| CORRESP | Letter to the SEC | May 22, 2025 | — |
| UPLOAD | Letter from the SEC | May 21, 2025 | — |
| EFFECT | Filing | Mar 14, 2025 | — |
| EFFECT | Filing | Mar 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 12, 2025 | — |
| CORRESP | Letter to the SEC | Mar 12, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| EFFECT | Filing | May 17, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2024 | — |
| EFFECT | Filing | Feb 8, 2024 | — |
| CORRESP | Letter to the SEC | Feb 6, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2024 | — |
| EFFECT | Filing | Feb 6, 2023 | — |
| CORRESP | Letter to the SEC | Feb 2, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2023 | — |
| D | Filing | Dec 9, 2022 | — |
| EFFECT | Filing | Aug 27, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2021 | — |
| CORRESP | Letter to the SEC | Aug 25, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| EFFECT | Filing | Mar 24, 2021 | — |
| CORRESP | Letter to the SEC | Mar 22, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2021 | — |
| D | Filing | Oct 26, 2020 | — |
| EFFECT | Filing | Oct 25, 2019 | — |
| CORRESP | Letter to the SEC | Oct 23, 2019 | — |
| CORRESP | Letter to the SEC | Oct 11, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2019 | — |
| D | Filing | Jul 31, 2019 | — |
| EFFECT | Filing | Mar 19, 2019 | — |
| CORRESP | Letter to the SEC | Mar 15, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2019 | — |
| EFFECT | Filing | Jan 25, 2018 | — |
| CT ORDER | Filing | Jan 25, 2018 | — |
| CERT | Filing | Jan 23, 2018 | — |
| 8-A12B | Filing | Jan 22, 2018 | — |
| CORRESP | Letter to the SEC | Jan 22, 2018 | — |
| CORRESP | Letter to the SEC | Jan 22, 2018 | — |
| CORRESP | Letter to the SEC | Jan 16, 2018 | — |
| CORRESP | Letter to the SEC | Jan 5, 2018 | — |
| DRS/A | Filing | Oct 23, 2017 | — |
| DRSLTR | Filing | Oct 20, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2017 | — |
| DRSLTR | Filing | Aug 4, 2017 | — |
| DRS | Filing | Aug 4, 2017 | — |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SLDB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Charlestown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1707502
- Former names
- Solid Biosciences, LLC (until Jan 25, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.